** Shares of Cyclopharm CYC.AX rise 6.6% to A$1.525, their highest level since February 27
** Radiopharmaceutical co says its signed a 5-year agreement with USA Veterans Administration
** The five-year Federal Supply Schedule $(FSS)$ agreement works to expand co's medical radioactive technology Technegas’ adoption within the US federal healthcare system
** Stock set for second straight session of gains
** CYC up 4.7% YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。